Western blot
0.2-1 ug/mlPositive Control: Jurkat cell lysate| Product Name | SLC18A2 antibody - N-terminal region |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | The immunogen for anti-SLC18A2 antibody: synthetic peptide directed towards the N terminal of human SLC18A2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| Species Reactivity | BovineDogHorseHumanMouseRabbit |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | SLC18A2 |
|---|---|
| Gene Synonyms | MGC120477 MGC120478 MGC26538 SVAT SVMT VAT2 VMAT2 |
| Gene Full Name | Solute carrier family 18 (vesicular monoamine), member 2 |
| Gene Summary | The vesicular monoamine transporter acts to accumulate cytosolic monoamines into synaptic vesicles, using the proton gradient maintained across the synaptic vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine. |
| Alternative Names | MGC120477 MGC120478 MGC26538 SVAT SVMT VAT2 VMAT2 |
| Molecular Weight(MW) | 56kDa |
| Sequence | 514 amino acids |
Western blot
0.2-1 ug/mlPositive Control: Jurkat cell lysate| Form | Liquid |
|---|---|
| Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
